Characteristics of Renal Cell Carcinoma Differ According to Genetic Ancestry
Among patients with renal cell carcinoma, clinical presentation, extent of disease, and germline and somatic alterations differ according to genetic ancestry.
Diagnosis & Disease Information
RCC Trials Use “Potentially Excessive” Exclusion Criteria
Renal cell carcinoma trials conducted in the past 10 years used exclusion criteria deemed potentially excessive by ASCO and FCR.
Researchers Characterize Gut Microbiome of Patients With mRCC and Sarcopenia
Sarcopenic patients with metastatic renal cell carcinoma have distinct bacterial populations that express metabolic pathways associated with a catabolic state.
Cryoablation More Effective for Some Early-Stage Renal Cell Carcinomas
Increased cancer-specific mortality seen with heat-based thermal ablation versus cryoablation for tumor size 3.1 to 4 cm
Outpatient Partial Nephrectomy Safety Probed
Study reveals an elevated risk for cardiac arrest and 30-day mortality associated with outpatient vs inpatient minimally invasive partial nephrectomy.
Risk Factors for Conversion From Partial to Radical Nephrectomy ID’d
Identifying which patients are at increased risk of conversion is important for shared decision making.
Cytoreductive Nephrectomy Added to ICI Therapy Ups Survival in mRCC
Use of cytoreductive nephrectomy with an immune checkpoint inhibitor reduced death risk by 67%.
Scoring System Differentiates Malignant and Benign Renal Masses
A validated algorithm for assessing solid renal masses could be useful in clinical practice.
How Patients Choose Small Renal Mass Treatment Characterized
Patients choosing active surveillance perceived cancer and metastasis risks to be lower compared with those opting for surgery and ablation, a study showed.
Progression Criteria Could Improve Active Surveillance for Renal Masses
Recent findings may be useful for patient counseling and in designing active surveillance research studies.
- Loading...
Loading...
Next post in IKCS 2022
Loading... 
Loading...